Is Dextrose + Dopamine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Dextrose + Dopamine, including Dopamine Hydrochloride in 5% Dextrose (800,50 µg/ml,g/l, Solution for injection/infusion, SAR 343.55).

Active substances

Dextrose + Dopamine

SFDA 1
Health Canada 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Dopamine Hydrochloride in 5% Dextrose	800,50 µg/ml,g/l	Solution for injection/infusion · Intravenous use	18 Bag	SAR 343.55	NCE · Prescription	BAXTER HEALTHCARE	Valid

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP	00761850	0.8 MG / ML; 50 MG / ML	SOLUTION · INTRAVENOUS	BAXTER CORPORATION
DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP	00761826	1.6 MG / ML; 50 MG / ML	SOLUTION · INTRAVENOUS	BAXTER CORPORATION
DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP	00761834	50 MG / ML; 3.2 MG / ML	SOLUTION · INTRAVENOUS	BAXTER CORPORATION

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.